Institution · Toscana Life Sciences
Most cited papers from Toscana Life Sciences
What are the most cited papers from Toscana Life Sciences?
The most cited paper from Toscana Life Sciences is "The IPD-IMGT/HLA Database" (Dominic J. Barker, Giuseppe Maccari, Xenia Georgiou et al., 2022), with 1,503 citations. Next come "A universal vaccine for serogroup B meningococcus" (729) and "Ten years of pan-genome analyses" (668).
Showing 50 of 60 papers. Every paper with more than 110 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | The IPD-IMGT/HLA Database Dominic J. Barker, Giuseppe Maccari, Xenia Georgiou et al. · Nucleic Acids Research | 21 Oct 2022 | 1,503 |
| 2 | A universal vaccine for serogroup B meningococcus Marzia Monica Giuliani et al. · Proceedings of the National Academy of Sciences | 6 Jul 2006 | 729 |
| 3 | Ten years of pan-genome analyses George S Vernikos, Duccio Medini, David R. J. Riley et al. · Current Opinion in Microbiology | 5 Dec 2014 | 668 |
| 4 | Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset type 1 diabetic patients Francesco Dotta, Stefano Censini, Astrid G. S. van Halteren et al. · Proceedings of the National Academy of Sciences | 14 Mar 2007 | 575 |
| 5 | Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome Fiona A. Sharp, Darren Ruane, Benjamin Claass et al. · Proceedings of the National Academy of Sciences | 12 Jan 2009 | 542 |
| 6 | The role of vaccines in combatting antimicrobial resistance Francesca Micoli, Fábio Bagnoli, Rino Rappuoli et al. · Nature Reviews Microbiology | 4 Feb 2021 | 511 |
| 7 | Pili in Gram-positive pathogens John L. Telford, Michèle A. Barocchi, Immaculada Margarit et al. · Nature Reviews Microbiology | 16 Jun 2006 | 455 |
| 8 | Vaccine manufacturing: challenges and solutions Jeffrey B. Ulmer, Ulrich Valley, Rino Rappuoli · Nature Biotechnology | Nov 2006 | 379 |
| 9 | SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma Emanuele Andreano, Giulia Piccini, Danilo Licastro et al. · Proceedings of the National Academy of Sciences | 20 Aug 2021 | 378 |
| 10 | Estimating and Modeling Relative Survival Paul William Dickman, Enzo Coviello · The Stata Journal Promoting communications on statistics and Stata | Apr 2015 | 361 |
| 11 | Group B Streptococcus: global incidence and vaccine development Atul Kumar Johri, Lawrence C. Paoletti, Philippe Glaser et al. · Nature Reviews Microbiology | 6 Nov 2006 | 337 |
| 12 | SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma Emanuele Andreano, Giulia Piccini, Danilo Licastro et al. · bioRxiv (Cold Spring Harbor Laboratory) | 28 Dec 2020 | 281 |
| 13 | The path to a successful vaccine adjuvant – ‘The long and winding road’ Derek T. O’Hagan, Ennio De Gregorio · Drug Discovery Today | 6 Mar 2009 | 275 |
| 14 | Incidence of ulnar neuropathy at the elbow in the province of Siena (Italy) Mauro Mondelli, Fabio Giannini, Michele Ballerini et al. · Journal of the Neurological Sciences | 21 Apr 2005 | 262 |
| 15 | A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets Piero Marchetti, Roberto Lupi, Marco Bugliani et al. · Diabetologia | 10 Sep 2012 | 258 |
| 16 | Changing Priorities in Vaccinology: Antibiotic Resistance Moving to the Top Aldo Tagliabue, Rino Rappuoli · Frontiers in Immunology | 30 May 2018 | 252 |
| 17 | Strategic priorities for respiratory syncytial virus (RSV) vaccine development Larry J. Anderson, Philip R. Dormitzer, D. James Nokes et al. · Vaccine | Apr 2013 | 245 |
| 18 | Extremely potent human monoclonal antibodies from COVID-19 convalescent patients Emanuele Andreano et al. · Cell | 23 Feb 2021 | 240 |
| 19 | Invariant NKT cells sustain specific B cell responses and memory Grazia Galli, Paola Pittoni, Elena Tonti et al. · Proceedings of the National Academy of Sciences | 27 Feb 2007 | 236 |
| 20 | Conventional and Neo-antigenic Peptides Presented by β Cells Are Targeted by Circulating Naïve CD8+ T Cells in Type 1 Diabetic and Healthy Donors Sergio Gonzalez-Duque et al. · Cell Metabolism | 2 Aug 2018 | 225 |
| 21 | Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics Mark R. Davies et al. · Nature Genetics | 27 May 2019 | 215 |
| 22 | Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptake Frank Liang, Gustaf Lindgren, Kerrie J. Sandgren et al. · Science Translational Medicine | 7 Jun 2017 | 211 |
| 23 | Outer membrane vesicle vaccines Francesca Micoli, Calman Alexander MacLennan · Seminars in Immunology | Aug 2020 | 207 |
| 24 | From empiricism to rational design: a personal perspective of the evolution of vaccine development Ennio De Gregorio, Rino Rappuoli · Nature reviews. Immunology | 13 Jun 2014 | 207 |
| 25 | Challenges for vaccination in the elderly Richard Aspinall, Giuseppe Del Giudice, Rita B. Effros et al. · Immunity & Ageing | Dec 2007 | 206 |
| 26 | Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance Linda Del Bino, Kitt Emilie Østerlid, Dung‐Yeh Wu et al. · Chemical Reviews | 24 May 2022 | 202 |
| 27 | SARS-CoV-2 Receptor Angiotensin I-Converting Enzyme Type 2 (ACE2) Is Expressed in Human Pancreatic β-Cells and in the Human Pancreas Microvasculature Daniela Fignani, Giada Licata, Noemi Brusco et al. · Frontiers in Endocrinology | 13 Nov 2020 | 202 |
| 28 | The in vitro transcription of the 7SK RNA gene by RNA polymerase III is dependent only on the presence of an upstream promoter Shona Murphy, Carlo Maria Di Liegro, Marialuisa Melli · Cell | Oct 1987 | 201 |
| 29 | Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice Andreas Wack, Barbara C. Baudner, Anne Katrin Hilbert et al. · Vaccine | 2008 | 195 |
| 30 | CD81 Is a Central Regulator of Cellular Events Required for Hepatitis C Virus Infection of Human Hepatocytes Michela Brazzoli, Alessia Bianchi, Sara Filippini et al. · Journal of Virology | 26 Jun 2008 | 193 |
| 31 | MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database Michele Pellegrini, Uwe Nicolay, KELLY A. LINDERT et al. · Vaccine | 13 Sep 2009 | 186 |
| 32 | Tics and Tourette syndrome in autism spectrum disorders Roberto Canitano, Giacomo Vivanti · Autism | 15 Dec 2006 | 182 |
| 33 | Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants Emanuele Andreano, Ida Paciello, Giulia Piccini et al. · Nature | 20 Oct 2021 | 181 |
| 34 | OMV Vaccines and the Role of TLR Agonists in Immune Response Francesca Mancini, Omar Rossi, Francesca Necchi et al. · International Journal of Molecular Sciences | 21 Jun 2020 | 178 |
| 35 | Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C Paolo A. Costantino, Stefano Viti, Audino Podda et al. · Vaccine | 1992 | 176 |
| 36 | The Development of a Vaccine Against Meningococcus B Using Reverse Vaccinology Vega Masignani, Mariagrazia Pizza, E. Richard Moxon · Frontiers in Immunology | 16 Apr 2019 | 168 |
| 37 | Towards the next generation of biomedicines by site-selective conjugation Qiying Hu, Francesco Berti, Roberto Adamo · Chemical Society Reviews | 2016 | 168 |
| 38 | Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB Christiane Gerke, Anna Maria Rosaria Colucci, Carlo Giannelli et al. · PLoS ONE | 6 Aug 2015 | 167 |
| 39 | Diagnostic utility of ultrasonography versus nerve conduction studies in mild carpal tunnel syndrome Mauro Mondelli, Georgios Filippou, Adriana Gallo et al. · Arthritis Care & Research | 29 Feb 2008 | 166 |
| 40 | Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules Matteo Stravalaci et al. · Nature Immunology | 31 Jan 2022 | 159 |
| 41 | Structural Basis for Potent Cross-Neutralizing Human Monoclonal Antibody Protection against Lethal Human and Zoonotic Severe Acute Respiratory Syndrome Coronavirus Challenge Barry Rockx, Davide Corti, Eric Donaldson et al. · Journal of Virology | 17 Jan 2008 | 157 |
| 42 | The use of genomics in microbial vaccine development Stefania Bambini, Rino Rappuoli · Drug Discovery Today | 16 Jan 2009 | 157 |
| 43 | Vaccines Against Antimicrobial Resistance Roberto Rosini, Sonia Nicchi, Mariagrazia Pizza et al. · Frontiers in Immunology | 3 Jun 2020 | 155 |
| 44 | Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines Despo Chatzikleanthous, Derek T. O’Hagan, Roberto Adamo · Molecular Pharmaceutics | 15 Jul 2021 | 149 |
| 45 | Public views on gene editing and its uses GEORGE D. GASKELL et al. · Nature Biotechnology | Nov 2017 | 149 |
| 46 | Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens Giulietta Maruggi, Emiliano Chiarot, Cinzia Giovani et al. · Vaccine | 7 Dec 2016 | 148 |
| 47 | Highways, byways and breadcrumbs: directing lymphocyte traffic in the lymph node Marc Bajénoff, Jackson G. Egen, Hai Qi et al. · Trends in Immunology | 11 Jul 2007 | 147 |
| 48 | Post‐genomic vaccine development Davide Serruto, Rino Rappuoli · FEBS Letters | 4 May 2006 | 145 |
| 49 | Structure of HCMV glycoprotein B in the postfusion conformation bound to a neutralizing human antibody Sumana Chandramouli, Claudio Ciferri, Pavel A. Nikitin et al. · Nature Communications | 14 Sep 2015 | 140 |
| 50 | Combination Vaccines DavidAG Skibinski, BarbaraC Baudner, Manmohan Singh et al. · Journal of Global Infectious Diseases | 2011 | 128 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.